Licensing & Tech Transfer

Rapid Technology Deployment Program Overview

Rapid Technology Deployment Program

To address the current national emergency, U.S. entities may be eligible to license select Sandia intellectual property at no cost for a limited time.

Program Overview

On March 13, 2020 President Trump officially declared the coronavirus pandemic a national emergency. To support the national efforts, many innovations at Sandia can and should be transitioned to practice as expeditiously as possible, without unnecessary delay or burden on our partners in industry. The Sandia Rapid Technology Deployment Program aims to get Sandia’s ideas and technology into industry as quickly and seamlessly as possible during this time of need.

Key Features

Any US company will be able to obtain a term-limited, non-negotiable, royalty-free, non-exclusive license under any available Sandia-owned United States patent that is not otherwise subject to a contractual obligation.

  • Licensees: Any US entity, person, company, university
  • Term: Now until December 31, 2020
  • Royalties: Zero
  • Negotiations: Zero
  • Rights: Non-exclusive

For more than seventy years, Sandia has provided exceptional service in the national interest, and this crisis is no different. Sandia looks forward to partnering in support of the national effort to mitigate the impacts of the coronavirus pandemic on our healthcare system and greater economy.

Please note: Rapid Technology Deployment license agreements do not include technical support. For information regarding funding opportunities for technical support, please visit Sandia's Technology Partnerships site.

How to Participate

Search for technologies in the Rapid Technology Deployment Program.
Once you have identified a patent or featured technology that is of interest, click Contact Us to complete and submit an inquiry form.
A Sandia representative will be in touch to discuss your licensing interest.
To expedite your RTD licensing request, download the fillable RTD License Agreement and Participant Data Sheet (PDS) above. Email completed forms to ip@sandia.gov.
Sandia National Laboratories has joined the Open COVID pledge to make patents freely available to address the pandemic and its effects.